Hong Kong Stock Market News | Uni-Bio Science Group (06990.HK) Surged over 9% in the afternoon as the US FDA recently approved the clinical trial application for SKB518, a new drug.

According to the Zhitong Finance and Economics APP, Hengrui Bio-B (06990.HK) rose more than 9% in the afternoon, as of the time of publication, it has risen by 8.53% to 328.2 Hong Kong dollars, with a turnover of 2.46 billion Hong Kong dollars.